Duavive (conjugated oestrogens/ bazedoxifene) approved for treatment of menopausal symptoms

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

July 04, 2016: Duavive (conjugated oestrogens/ bazedoxifene) is licensed for the treatment of oestrogen deficiency symptoms in postmenopausal women with a uterus who are at least one year after their last period, when progestin-containing therapy is not suitable.

Duavive combines conjugated oestrogens with the selective oestrogen receptor modulator (SER...

Recommended for you

  • Drug Updates
  • 1 comment

Misoprostol vaginal delivery system (Mysodelle): reports of excessive uterine contractions

  • Drug Updates
  • 1 comment

Incidence of death and fractures reported with concomitant use of radium-223 dichloride (Xofigo▼) and abiraterone, prednisone/prednisolone

  • Drug Updates
  • 1 comment

Use of gadolinium-containing contrast agents like gadodiamide (Omniscan) and intravenous gadopentetic acid (Magnevist) suspended

  • Drug Updates
  • 1 comment

Fingolimod (Gilenya▼): Risk of serious cardiac arrhythmias

  • Drug Updates
  • 1 comment

Fingolimod (Gilenya▼): Risk of skin cancer, lymphoma and serious opportunistic infections

  • Drug Updates
  • 1 comment

Eluxadoline (Truberzi▼): Risk of pancreatitis and contraindication in patients who have undergone cholecystectomy or with biliary disorders

  • Drug Updates
  • 1 comment

Reports of progressive multifocal encephalopathy (PML) post-treatment with Cladribine (Litak, Leustat) for leukaemia

  • Drug Updates
  • 1 comment

Inadvertent switching between brands of tacrolimus associated with reports of toxicity and graft rejection

  • Drug Updates
  • 1 comment

Quinine: Dose-dependent effects on QT interval and drug interactions

  • Drug Updates
  • 1 comment

Patient-related factors and 3 risk-based categories should be considered while prescribing antiepileptic drugs

  • Drug Updates
  • 1 comment

Reports of some batches of gentamicin sulphate active pharmaceutical ingredient containing higher than expected histamine levels

  • Drug Updates
  • 1 comment

Gabapentin (Neurontin): Risk of developing respiratory depression without concomitant use of opioids

  • Drug Updates
  • 1 comment

Do not use Solu-Medrone 40 mg in patients with a known or suspected allergy to cows’ milk

  • Drug Updates
  • no comment

Isotretinoin (Roaccutane): Risk of sexual side effects like erectile dysfunction and decreased libido

  • Drug Updates
  • 1 comment

Clozapine associated with risk of intestinal obstruction, faecal impaction, and paralytic ileus

  • Drug Updates
  • 1 comment

Loperamide (Imodium): Overdoses of loperamide associated with risk of serious cardiovascular events

  • Drug Updates
  • 1 comment

Patients on warfarin should not use over-the-counter Miconazole oral gel (Daktarin)

  • Drug Updates
  • 1 comment

Revised recommendations for use of adrenaline auto-injectors post European review

  • Drug Updates
  • 1 comment

Ibrutinib (Imbruvica▼): Reported cases of ventricular tachyarrhythmia and risk of hepatitis B reactivation and opportunistic infections

  • Drug Updates
  • 1 comment

Local and systemic administration of corticosteroids: risk of central serous chorioretinopathy

  • Drug Updates
  • 1 comment

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

  • Drug Updates
  • 1 comment

Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): Risk of graft rejection

  • Drug Updates
  • 1 comment

Bendamustine (Levact): Increased mortality when used in combination treatment outside the approved indications

  • Drug Updates
  • 1 comment

Denosumab (Prolia, Xgeva▼): Risk of osteonecrosis of jaw and external auditory canal

  • Drug Updates
  • 1 comment

Brimonidine gel (Mirvaso): Risk of cardiovascular events if applied to damaged skin

  • Drug Updates
  • 1 comment

Restrictions to manage the risk for misuse of pseudoephedrine and ephedrine to be continued

  • Drug Updates
  • no comment

Yellow Card Scheme Website: Report any side effects or safety concerns with e-cigarettes and e-liquids

  • Drug Updates
  • 1 comment

Finasteride 1 mg (Propecia): Reports of depression and suicidal thoughts in men

  • Drug Updates
  • 1 comment

Valproate (Epilim▼, Depakote▼): High risk of neurodevelopmental disability and birth defects

  • Drug Updates
  • 1 comment

Ponatinib (Iclusig▼): Risk of vascular arterial occlusion is dose-dependent